*Disclaimer : This is as of previous day’s closing price.
Below is a quick look at 5 technical indicators for CRISPR Therapeutics AG. More studies are available on the Technical Chart.
|Closing Price above/below 50 Day Moving Average||Bearish|
|Closing Price above/below 200 Day Moving Average||Bullish|
|50 Day Moving Average above/below 200 Day Moving Average||Bullish|
|RSI Reading Level (<30 or >70)||Fair Value|
|MACD Compared to 9D EMA Signal Line||Bullish|
View these and more technical studies for CRISPR Therapeutics AG
Share Price Performance Relative to Peers
CRSP-US has traded publicly for less than a year.
CRSP-US’s shares have traded publicly for less than a year. Over the last one month, however, the company’s share price has relatively underperformed with a return of -1.83% vs. peer median of 8.11%.
Screen for companies using relative share price performance
CRISPR Therapeutics AG has an earnings score of 51.13 and has a relative valuation of OVERVALUED.
Stocks with High Earnings Momentum are a preferred option for momentum plays. If they are undervalued, it can be a further advantage and may indicate sustained momentum.
Quadrant label definitions. Hover to know more
Screen for companies using Earnings Momentum Score
The information presented in this report has been obtained from sources deemed to be reliable, but AnalytixInsight does not make any representation about the accuracy, completeness, or timeliness of this information. This report was produced by AnalytixInsight for informational purposes only and nothing contained herein should be construed as an offer to buy or sell or as a solicitation of an offer to buy or sell any security or derivative instrument. This report is current only as of the date that it was published and the opinions, estimates, ratings and other information may change without notice or publication. Past performance is no guarantee of future results. Prior to making an investment or other financial decision, please consult with your financial, legal and tax advisors. AnalytixInsight shall not be liable for any party’s use of this report. AnalytixInsight is not a broker-dealer and does not buy, sell, maintain a position, or make a market in any security referred to herein. One of the principal tenets for us at AnalytixInsight is that the best person to handle your finances is you. By your use of our services or by reading any of our reports, you’re agreeing that you bear responsibility for your own investment research and investment decisions. You also agree that AnalytixInsight, its directors, its employees, and its agents will not be liable for any investment decision made or action taken by you and others based on news, information, opinion, or any other material generated by us and/or published through our services. For a complete copy of our disclaimer, please visit our website www.analytixinsight.com.